Granules India has reported results for fourth quarter ended March 31, 2012
The company has posted a rise of 79.59% in its net profit at Rs 14.78 crore for the quarter ended March 31, 2012 as compared to Rs 8.23 crore for the same quarter in the previous year. Total income has increased by 57.89% at Rs 165.42 crore for quarter under review as compared to Rs 104.77 crore for the quarter ended March 31, 2011.
On the consolidated basis, the company has posted a rise of 85.81% in its net profit at Rs 16.37 crore for the quarter ended March 31, 2012 as compared to Rs 8.81 crore for the same quarter in the previous year. Total income has increased by 56.89% at Rs 188.09 crore for quarter under review as compared to Rs 119.89 crore for the quarter ended March 31, 2011.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1505.20 |
Dr. Reddys Lab | 5922.45 |
Cipla | 1339.45 |
Zydus Lifesciences | 983.05 |
Lupin | 1609.85 |
View more.. |